Molina Healthcare (NYSE:MOH) updated its FY18 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $3.23-3.73 for the period, compared to the Thomson Reuters consensus estimate of $3.59. The company issued revenue guidance of $18.8 billion, compared to the consensus revenue estimate of $19.86 billion.

Several research firms have recently commented on MOH. JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a neutral rating to an overweight rating in a research report on Tuesday, January 16th. Leerink Swann upped their price objective on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an outperform rating in a research note on Tuesday, January 9th. Morgan Stanley reduced their price objective on shares of Molina Healthcare from $97.00 to $94.00 and set an overweight rating on the stock in a research note on Wednesday, February 7th. Zacks Investment Research raised shares of Molina Healthcare from a sell rating to a hold rating in a research note on Monday, November 6th. Finally, ValuEngine downgraded shares of Molina Healthcare from a buy rating to a hold rating in a research note on Friday, December 1st. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of $71.21.

Molina Healthcare (NYSE:MOH) opened at $78.39 on Tuesday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market cap of $4,682.10, a P/E ratio of 24.36, a price-to-earnings-growth ratio of 0.91 and a beta of 1.10. Molina Healthcare has a one year low of $42.56 and a one year high of $93.98.

In other Molina Healthcare news, insider William Dentino sold 67,500 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $77.15, for a total transaction of $5,207,625.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director John C. Molina sold 21,650 shares of the stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $92.41, for a total transaction of $2,000,676.50. Following the transaction, the director now directly owns 414,151 shares in the company, valued at approximately $38,271,693.91. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 771,205 shares of company stock worth $61,211,000. 6.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Molina Healthcare (MOH) Releases FY18 Earnings Guidance” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://theolympiareport.com/2018/02/13/molina-healthcare-moh-releases-fy18-earnings-guidance.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.